If AstraZeneca goes to the US, it will be a major blow for London and Labour
Move would deprive LSE of its biggest star and could topple a key pillar of the government’s industrial strategy Three years ago Pascal Soriot received the ultimate accolade for turning around AstraZeneca – a knighthood for services to UK life sciences and leadership in the global response to the (...)
Site référencé: The Guardian
AstraZeneca, Business, Pharmaceuticals industry, London Stock Exchange, Industrial policy, Politics, Labour, UK news
5353.jpg?width=140&quality=85&auto=format&fit=max&s=93b728c40aa4d3b43e85598e8ca6f83d, 5353.jpg?width=460&quality=85&auto=format&fit=max&s=8975c487edd09145e98f1e9a6f9b5cd1
The Guardian
Homes for sale with outbuildings and studios in England and Wales – in pictures
4/07/2025
Japan walks line between recession and submission as it seeks to overcome Trump tariffs
4/07/2025
Who’s really to blame for Labour’s troubles – Rachel Reeves or the invisible PM ? | Gaby Hinsliff
4/07/2025
TfL faces legal action over licence delays for Uber and other private hire drivers
4/07/2025
UK electric car sales up by a third in first half of 2025, preliminary data suggests
4/07/2025
Housing minister vows to crack down on property management ‘wild west’
4/07/2025
